A clinical double-blind trial of topical haloprogin and miconazole against superficial fungal infections

Abstract

A clinical double‐blind trial of topical haloprogin ointment and miconazole cream was carried out against superficial fungal infections of the skin and erythrasma. The trial showed that haloprogin had the same broad range of activity as miconazole being effective against dermatophyte, pityriasis versicolor, Candida and erythrasma infections. Patient acceptability was not as good for haloprogin as it was for miconazole.